Status:
COMPLETED
Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Endometriosis
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following IVF outcome
Eligibility Criteria
Inclusion
- Endometrioma(s)with a size of 20-70 mm, persisted for at least 3 cycles
- Couples with indication and wish for IVF/ICSI
- Age of women: 20-40 years
- Regular menstrual cycle within normal range (21-35 days)
- Body Mass Index (BMI): 18-30 kg/m2
Exclusion
- History with osteoporosis, liver-, kidney- or heart disease or thromboembolic disease
- Treatment of endometriosis with GnRH agonist during the last 3 month
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00286351
Start Date
January 1 2005
Last Update
April 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Copenhagen East, Denmark, 2100